Stem cell transplantation for muscular dystrophy: The challenge of immune response

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Maffioletti, Sara Martina ^a   Noviello, Maddalena ^b   English, Karen ^c   Tedesco, Francesco Saverio ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; PROGRAMMED DEATH 1 LIGAND 1; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL REGENERATION; CELL THERAPY; CELLULAR IMMUNITY; DENDRITIC CELL; ENGRAFTMENT; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MUSCLE CELL; MUSCLE DISEASE; MUSCLE INJURY; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOSITIS; NONHUMAN; OUTCOME ASSESSMENT; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; T LYMPHOCYTE ACTIVATION; XENOGRAFT; ANIMAL; CELL MOTION; CLINICAL TRIAL (TOPIC); CYTOLOGY; DISEASE MODEL; HUMAN; INFLAMMATION; MUSCULAR DYSTROPHIES; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; REGENERATIVE MEDICINE; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84904103021     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/964010     Document Type: Review

References (136)

1. Mercuri E., Muntoni F., Muscular dystrophies. The Lancet 2013 381 9869 845 860 10.1016/S0140-6736(12)61897-2 2-s2.0-84874692333
2. Benedetti S., Hoshiya H., Tedesco F. S., Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies. The FEBS Journal 2013 280 17 4263 4280 10.1111/febs.12178 2-s2.0-84882656215
3. Tedesco F. S., Cossu G., Stem cell therapies for muscle disorders. Current Opinion in Neurology 2012 25 5 597 603 10.1097/WCO.0b013e328357f288 2-s2.0-84866336634
4. Fan Y., Maley M., Beilharz M., Grounds M., Rapid death of injected myoblasts in myoblast transfer therapy. Muscle & Nerve 1996 19 853 860 (Pubitemid 26190645)
5. Beauchamp J. R., Pagel C. N., Partridge T. A., A dual-marker system for quantitative studies of myoblast transplantation in the mouse. Transplantation 1997 63 12 1794 1797 10.1097/00007890-199706270-00015 2-s2.0-0031008874 (Pubitemid 27278953)
6. Hodgetts S. I., Beilharz M. W., Scalzo A. A., Grounds M. D., Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or NK1.1+ cells. Cell Transplantation 2000 9 4 489 502 2-s2.0-0033775506
7. Skuk D., Tremblay J. P., Myoblast Transplantation in Skeletal Muscles. Handbook of Stem Cells 2013 2nd 653 664
8. Teener J. W., Inflammatory and toxic myopathy. Seminars in Neurology 2012 32 5 491 499 10.1055/s-0033-1334467 2-s2.0-84878046221
9. Gayraud-Morel B., Chrétien F., Tajbakhsh S., Skeletal muscle as a paradigm for regenerative biology and medicine. Regenerative Medicine 2009 4 2 293 319 10.2217/17460751.4.2.293 2-s2.0-65549084780
10. Mauro A., Satellite cell of skeletal muscle fibers. The Journal of Biophysical and Biochemical Cytology 1961 9 493 495 10.1083/jcb.9.2.493 2-s2.0-0000642664
11. Relaix F., Zammit P. S., Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 2012 139 16 2845 2856 10.1242/dev.069088 2-s2.0-84864317860
12. Tedesco F. S., Dellavalle A., Diaz-Manera J., Messina G., Cossu G., Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. Journal of Clinical Investigation 2010 120 1 11 19 10.1172/JCI40373 2-s2.0-74949112463
13. St. Pierre B. A., Tidball J. G., Differential response of macrophage subpopulations to soleus muscle reloading after rat hindlimb suspension. Journal of Applied Physiology 1994 77 1 290 297 2-s2.0-0028234349 (Pubitemid 24226148)
14. Brigitte M., Schilte C., Plonquet A., Baba-Amer Y., Henri A., Charlier C., Tajbakhsh S., Albert M., Gherardi R. K., Chrétien F., Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury. Arthritis and Rheumatism 2010 62 1 268 279 10.1002/art.27183 2-s2.0-74849087161
15. Tidball J. G., Villalta S. A., Regulatory interactions between muscle and the immune system during muscle regeneration. American Journal of Physiology 2010 298 5 R1173 R1187 10.1152/ajpregu.00735.2009 2-s2.0-77951700255
16. Warren G. L., Hulderman T., Jensen N., McKinstry M., Mishra M., Luster M. I., Simeonova P. P., Physiological role of tumor necrosis factor alpha in traumatic muscle injury. The FASEB Journal 2002 16 12 1630 1632 2-s2.0-0036778388
17. (-/-) mice. Journal of Histochemistry and Cytochemistry 2001 49 8 989 1001 10.1177/002215540104900807 2-s2.0-0034923715 (Pubitemid 32675006)
18. Radley H. G., Grounds M. D., Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice. Neurobiology of Disease 2006 23 2 387 397 10.1016/j.nbd.2006.03.016 2-s2.0-33746239685 (Pubitemid 44097034)
19. Li Y.-P., TNF- α is a mitogen in skeletal muscle. The American Journal of Physiology-Cell Physiology 2003 285 2 C370 C376 10.1152/ajpcell. 00453.2002 2-s2.0-0042242879
20. Langen R. C. J., Van Der Velden J. L. J., Schols A. M. W. J., Kelders M. C. J. M., Wouters E. F. M., Janssen-Heininger Y. M. W., Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB Journal 2004 18 2 227 237 10.1096/fj.03-0251com 2-s2.0-0442324933 (Pubitemid 38186242)
21. Guttridge D. C., Albanese C., Reuther J. Y., Pestell R. G., Baldwin A. S. Jr., NF- B controls cell growth and differentiation through transcriptional regulation of cyclin D1. Molecular and Cellular Biology 1999 19 8 5785 5799 2-s2.0-0032588186 (Pubitemid 29339933)
22. Langen R. C. J., Schols A. M. W. J., Kelders M. C. J. M., Wouters E. F. M., Janssen-Heininger Y. M. W., Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor- B. The FASEB Journal 2001 15 7 1169 1180 10.1096/fj.00-0463 2-s2.0-0035020963 (Pubitemid 32436302)
23. Bakkar N., Wang J., Ladner K. J., Wang H., Dahlman J. M., Carathers M., Acharyya S., Rudnicki M. A., Hollenbach A. D., Guttridge D. C., IKK/NF- B regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. The Journal of Cell Biology 2008 180 4 787 802 10.1083/jcb.200707179 2-s2.0-40849083857 (Pubitemid 351397778)
24. Summan M., McKinstry M., Warren G. L., Hulderman T., Mishra D., Brumbaugh K., Luster M. I., Simeonova P. P., Inflammatory mediators and skeletal muscle injury: a DNA microarray analysis. Journal of Interferon and Cytokine Research 2003 23 5 237 245 10.1089/107999003321829953 2-s2.0-0038412811 (Pubitemid 36606456)
25. Warren G. L., O'Farrell L., Summan M., Hulderman T., Mishra D., Luster M. I., Kuziel W. A., Simeonova P. P., Role of CC chemokines in skeletal muscle functional restoration after injury. The American Journal of Physiology-Cell Physiology 2004 286 5 C1031 C1036 10.1152/ajpcell.00467.2003 2-s2.0-1942422716 (Pubitemid 38506918)
26. Ochoa O., Sun D., Reyes-Reyna S. M., Waite L. L., Michalek J. E., McManus L. M., Shireman P. K., Delayed angiogenesis and VEGF production in CCR2-/- mice during impaired skeletal muscle regeneration. American Journal of Physiology 2007 293 2 R651 R661 10.1152/ajpregu.00069.2007 2-s2.0-34547619196 (Pubitemid 47205047)
27. Yahiaoui L., Gvozdic D., Danialou G., Mack M., Petrof B. J., CC family chemokines directly regulate myoblast responses to skeletal muscle injury. The Journal of Physiology 2008 586 16 3991 4004 10.1113/jphysiol.2008.152090 2-s2.0-50049089622
28. Filippin L. I., Cuevas M. J., Lima E., Marroni N. P., Gonzalez-Gallego J., Xavier R. M., Nitric oxide regulates the repair of injured skeletal muscle. Nitric Oxide: Biology and Chemistry 2011 24 1 43 49 10.1016/j.niox.2010.11.003 2-s2.0-79251628731
29. Anderson J. E., A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Molecular Biology of the Cell 2000 11 5 1859 1874 10.1091/mbc.11.5.1859 2-s2.0-0034071559 (Pubitemid 30307918)
30. Bondesen B. A., Mills S. T., Kegley K. M., Pavlath G. K., The COX-2 pathway is essential during early stages of skeletal muscle regeneration. The American Journal of Physiology-Cell Physiology 2004 287 2 C475 C483 10.1152/ajpcell.00088.2004 2-s2.0-3242679772 (Pubitemid 38955239)
31. Zalin R. J., The role of hormones and prostanoids in the in vitro proliferation and differentiation of human myoblasts. Experimental Cell Research 1987 172 2 265 281 10.1016/0014-4827(87)90386-7 2-s2.0-0023550012 (Pubitemid 18025331)
32. Schutzle U. B., Wakelam M. J. O., Pette D., Prostaglandins and cyclic AMP stimulate creatine kinase synthesis but not fusion in cultured embryonic chick muscle cells. Biochimica et Biophysica Acta 1984 805 2 204 210 10.1016/0167-4889(84)90169-1 2-s2.0-0021205088 (Pubitemid 14017841)
33. Zalin R. J., Prostaglandins and myoblast fusion. Developmental Biology 1977 59 2 241 248 10.1016/0012-1606(77)90258-5 2-s2.0-0017642119 (Pubitemid 8163880)
34. Arnold L., Henry A., Poron F., Baba-Amer Y., Van Rooijen N., Plonquet A., Gherardi R. K., Chazaud B., Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. The Journal of Experimental Medicine 2007 204 5 1057 1069 10.1084/jem.20070075 2-s2.0-34248997759 (Pubitemid 46798150)
35. Gordon S., Alternative activation of macrophages. Nature Reviews Immunology 2003 3 1 23 35 10.1038/nri978 2-s2.0-0037265240 (Pubitemid 37328697)
36. Horsley V., Jansen K. M., Mills S. T., Pavlath G. K., IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 2003 113 4 483 494 10.1016/S0092-8674(03)00319-2 2-s2.0-0037726553 (Pubitemid 36588751)
37. Pedersen B. K., Muscle as a secretory organ. Comprehensive Physiology 2013 3 1337 1362
38. Plomgaard P., Penkowa M., Pedersen B. K., Fiber type specific expression of TNF-alpha, IL-6 and IL-18 in human skeletal muscles. Exercise Immunology Review 2005 11 53 63 2-s2.0-33646347676
39. Lu H., Huang D., Ransohoff R. M., Zhou L., Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB Journal 2011 25 10 3344 3355 10.1096/fj.10-178939 2-s2.0-80053903736
40. Serrano A. L., Baeza-Raja B., Perdiguero E., Jardí M., Muñoz-Cánoves P., Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metabolism 2008 7 1 33 44 10.1016/j.cmet.2007.11.011 2-s2.0-37449022587
41. Pedersen B. K., Steensberg A., Fischer C., Keller C., Ostrowski K., Schjerling P., Exercise and cytokines with particular focus on muscle-derived IL-6. Exercise Immunology Review 2001 7 18 31 2-s2.0-0034813001 (Pubitemid 32911041)
42. de Paepe B., de Bleecker J. L., Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of duchenne muscular dystrophy. Mediators of Inflammation 2013 2013 10 540370 10.1155/2013/540370
43. Manzur A. Y., Kuntzer T., Pike M., Swan A., Glucocorticoid corticosteroids for Duchenne muscular dystrophy. The Cochrane Database of Systematic Reviews 2008 1 CD003725 2-s2.0-41949096517
44. Villalta S. A., Nguyen H. X., Deng B., Gotoh T., Tidbal J. G., Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Human Molecular Genetics 2009 18 3 482 496 10.1093/hmg/ddn376 2-s2.0-58749098598
45. Wehling-henricks M., Sokolow S., Lee J. J., Myung K. H., Villalta S. A., Tidball J. G., Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Human Molecular Genetics 2008 17 15 2280 2292 10.1093/hmg/ddn129 2-s2.0-48049084529
46. Gussoni E., Pavlath G. K., Miller R. G., Panzara M. A., Powell M., Blau H. M., Steinman L., Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy. Journal of Immunology 1994 153 10 4798 4805 2-s2.0-0028075601 (Pubitemid 24346875)
47. +) T cells promote the pathology of dystrophin-deficient muscle. Clinical Immunology 2001 98 2 235 243 10.1006/clim.2000.4966 2-s2.0-0035122405 (Pubitemid 32150612)
48. Flanigan K. M., Campbell K., Viollet L., Wang W., Gomez A. M., Walker C. M., Mendell J. R., Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect. Human Gene Therapy 2013 24 9 797 806 10.1089/hum.2013.092
49. Hauerslev S., Orngreen M. C., Hertz J. M., Vissing J., Krag T. O., Muscle regeneration and inflammation in patients with facioscapulohumeral muscular dystrophy. Acta Neurologica Scandinavica 2013 128 3 194 201 10.1111/ane.12109 2-s2.0-84881667127
50. Nagaraju K., Rawat R., Veszelovszky E., Thapliyal R., Kesari A., Sparks S., Raben N., Plotz P., Hoffman E. P., Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B. The American Journal of Pathology 2008 172 3 774 785 10.2353/ajpath.2008.070327 2-s2.0-40449085244 (Pubitemid 351354549)
51. Figarella-Branger D., Civatte M., Bartoli C., Pellissier J., Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle & Nerve 2003 28 6 659 682 10.1002/mus.10462 2-s2.0-0344875464 (Pubitemid 37484828)
52. Nagaraju K., Raben N., Merritt G., Loeffler L., Kirk K., Plotz P., A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clinical and Experimental Immunology 1998 113 3 407 414 10.1046/j.1365-2249. 1998.00664.x 2-s2.0-0031660980 (Pubitemid 28410566)
53. Boyd J. H., Divangahi M., Yahiaoui L., Gvozdic D., Qureshi S., Petrof B. J., Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF- B and calcineurin. Infection and Immunity 2006 74 12 6829 6838 10.1128/IAI.00286-06 2-s2.0-33845482683 (Pubitemid 44913158)
54. Schreiner B., Voss J., Wischhusen J., Dombrowski Y., Steinle A., Lochmüller H., Dalakas M., Melms A., Wiendl H., Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. FASEB Journal 2006 20 1 118 120 10.1096/fj.05-4342fje 2-s2.0-30744473746 (Pubitemid 43100486)
55. Roy R., Dansereau G., Tremblay J. P., Belles-Isles M., Huard J., Labrecque C., Bouchard J. P., Expression of major histocompatibility complex antigens on human myoblasts. Transplantation Proceedings 1991 23 1 799 801 2-s2.0-0025980012
56. Mantegazza R., Hughes S. M., Mitchell D., Travis M., Blau H. M., Steinman L., Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN- γ Neurology 1991 41 7 1128 1132 10.1212/WNL.41.7.1128 2-s2.0-0026000528
57. Karpati G., Pouliot Y., Carpenter S., Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Annals of Neurology 1988 23 1 64 72 10.1002/ana.410230111 2-s2.0-0023794825
58. Englund P., Lindroos E., Nennesmo I., Klareskog L., Lundberg I. E., Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. The American Journal of Pathology 2001 159 4 1263 1273 10.1016/S0002-9440(10) 62513-8 2-s2.0-0034790176 (Pubitemid 32947956)
59. Wiendl H., Lautwein A., Mitsdörffer M., Krause S., Erfurth S., Wienhold W., Morgalla M., Weber E., Overkleeft H. S., Lochmüller H., Melms A., Tolosa E., Driessen C., Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies. Journal of Neuroimmunology 2003 138 1-2 132 143 10.1016/S0165-5728(03)00093-6 2-s2.0-20244366658 (Pubitemid 36566427)
60. Ferrer I., Martín B., Castaño J. G., Lucas J. J., Moreno D., Olivé M., Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. Journal of Neuropathology and Experimental Neurology 2004 63 5 484 498 2-s2.0-2442651500 (Pubitemid 38669669)
61. Saito A., Higuchi I., Nakagawa M., Saito M., Uchida Y., Inose M., Kasai T., Niiyama T., Fukunaga H., Arimura K., Osame M., An overexpression of fibroblast growth factor (FGF) and FGF receptor 4 in a severe clinical phenotype of facioscapulohumeral muscular dystrophy. Muscle & Nerve 2000 23 490 497 (Pubitemid 30164773)
62. Cassano M., Dellavalle A., Tedesco F. S., Quattrocelli M., Crippa S., Ronzoni F., Salvade A., Berardi E., Torrente Y., Cossu G., Sampaolesi M., Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo. Development 2011 138 20 4523 4533 10.1242/dev.070706 2-s2.0-80053089526
63. Bocelli-Tyndall C., Zajac P., di Maggio N., Trella E., Benvenuto F., Iezzi G., Scherberich A., Barbero A., Schaeren S., Pistoia V., Spagnoli G., Vukcevic M., Martin I., Tyndall A., Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells. Arthritis & Rheumatism 2010 62 12 3815 3825 10.1002/art.27736 2-s2.0-78650061560
64. Wiendl H., Behrens L., Maier S., Johnson M. A., Weiss E. H., Hohlfeld R., Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G. Annals of Neurology 2000 48 679 684 10.1002/1531-8249(200010)48:4<679::AID-ANA19>3.0.CO;2-V
65. Rouas-Freiss N., Gonçalves R. M., Menier C., Dausset J., Carosella E. D., Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proceedings of the National Academy of Sciences of the United States of America 1997 94 21 11520 11525 10.1073/pnas.94.21.11520 2-s2.0-0030848809 (Pubitemid 27451031)
66. Carosella E. D., Moreau P., Aractingi S., Rouas-Freiss N., HLA-G: a shield against inflammatory aggression. Trends in Immunology 2001 22 10 553 555 10.1016/S1471-4906(01)02007-5 2-s2.0-0035472077 (Pubitemid 33016401)
67. Behrens L., Kerschensteiner M., Misgeld T., Goebels N., Wekerle H., Hohlfeld R., Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. The Journal of Immunology 1998 161 5943 5951 (Pubitemid 28535962)
68. Murata K., Dalakas M. C., Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. The American Journal of Pathology 1999 155 2 453 460 10.1016/S0002-9440(10)65141-3 2-s2.0-0032797798 (Pubitemid 29370395)
69. Fries K. M., Sempowski G. D., Gaspari A. A., Blieden T., Looney R. J., Phipps R. P., CD40 expression by human fibroblasts. Clinical Immunology and Immunopathology 1995 77 1 42 51 10.1016/0090-1229(95)90135-3 2-s2.0-0028872078
70. Karmann K., Hughes C. C. W., Schechner J., Fanslow W. C., Pober J. S., CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proceedings of the National Academy of Sciences of the United States of America 1995 92 10 4342 4346 10.1073/pnas.92.10.4342 2-s2.0-0029073133
71. Sugiura T., Kawaguchi Y., Harigai M., Takagi K., Ohta S., Fukasawa C., Hara M., Kamatani N., Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production. Journal of Immunology 2000 164 12 6593 6600 10.4049/jimmunol.164.12.6593 2-s2.0-0034659757 (Pubitemid 30408846)
72. Bartoccioni E., Gallucci S., Scuderi F., Ricci E., Servidei S., Broccolini A., Tonali P., MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clinical and Experimental Immunology 1994 95 1 166 172 2-s2.0-0028362071 (Pubitemid 24207121)
73. Tews D. S., Goebel H. H., Expression of cell adhesion molecules in inflammatory myopathies. Journal of Neuroimmunology 1995 59 1-2 185 194 10.1016/0165-5728(95)00045-4 2-s2.0-0029015389
74. Malorni W., Iosi F., Zarcone D., Grossi C. E., Arancia G., De Harven E., Kang Y. H., Graf L. H., Role of adhesion molecules in the mechanism of non-MHC (major histocompatibility complex) restricted cell-mediated cytotoxicity. Scanning Microscopy 1993 7 1 323 332 2-s2.0-0027554798 (Pubitemid 23138238)
75. Francisco L. M., Sage P. T., Sharpe A. H., The PD-1 pathway in tolerance and autoimmunity. Immunological Reviews 2010 236 1 219 242 10.1111/j.1600-065X. 2010.00923.x 2-s2.0-77953747963
76. English K., Tonlorenzi R., Cossu G., Wood K. J., Mesoangioblasts suppress T cell proliferation through IDO and PGE-2-dependent pathways. Stem Cells and Development 2013 22 3 512 523 10.1089/scd.2012.0386 2-s2.0-84872734102
77. Wiendl H., Mitsdoerffer M., Schneider D., Chen L., Lochmller H., Melms A., Weller M., Lochmüller H., Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEB Journal 2003 17 13 1892 1894
78. Lesault P. F., Theret M., Magnan M., Cuvellier S., Niu Y., Gherardi R. K., Tremblay J. P., Hittinger L., Chazaud B., Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle. PLoS ONE 2012 7 10 e46698 10.1371/journal.pone.0046698 2-s2.0-84867090688
79. Lolmede K., Campana L., Vezzoli M., Bosurgi L., Tonlorenzi R., Clementi E., Bianchi M. E., Cossu G., Manfredi A. A., Brunelli S., Rovere-Querini P., Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. Journal of Leukocyte Biology 2009 85 5 779 787 10.1189/jlb.0908579 2-s2.0-65549151760
80. Torrente Y., El Fahime E., Caron N. J., Del Bo R., Belicchi M., Pisati F., Tremblay J. P., Bresolin N., Tumor necrosis factor- α (TNF- α) stimulates chemotactic response in mouse myogenic cells. Cell Transplantation 2003 12 1 91 100 10.3727/000000003783985115 2-s2.0-0037242916 (Pubitemid 36397320)
81. Page G., Chevrel G., Miossec P., Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells. Arthritis and Rheumatism 2004 50 1 199 208 10.1002/art.11428 2-s2.0-0347719268 (Pubitemid 38084305)
82. Schwab N., Waschbisch A., Wrobel B., Lochmüller H., Sommer C., Wiendl H., Human myoblasts modulate the function of antigen-presenting cells. Journal of Neuroimmunology 2008 200 1-2 62 70 10.1016/j.jneuroim.2008.06.012 2-s2.0-49849090483
83. Li O., English K., Tonlorenzi R., Cossu G., Tedesco F. S., Wood K. J., Human iPSC-derived mesoangioblasts, like their tissue-derived counterparts, suppress T cell proliferation through IDO- and PGE-2-dependent pathways. F1000 Research 2013 2, article 24
84. Noviello M., Tedesco F. S., Bondanza A., Tonlorenzi R., Rosaria Carbone M., Gerli M. F., Marktel S., Napolitano S., Cicalese M. P., Ciceri F., Peretti G., Cossu G., Bonini C., Inflammation converts human mesoangioblasts into targets of alloreactive immune responses: implications for allogeneic cell therapy of DMD. Molecular therapy 2014 10.1038/mt.2014.62
85. Nguyen H. X., Tidball J. G., Interactions between neutrophils and macrophages promote macrophage killing of rat muscle cells in vitro. The Journal of Physiology 2003 547 1 125 132 10.1113/jphysiol.2002.031450 2-s2.0-0037440706 (Pubitemid 36285168)
86. Noone C., Kihm A., English K., O'Dea S., Mahon B. P., IFN- γ stimulated human umbilical-tissue-derived cells potently suppress NK activation and resist NK-mediated cytotoxicity in vitro. Stem Cells and Development 2013 22 22 3003 3014 10.1089/scd.2013.0028
87. Partridge T. A., The mdx mouse model as a surrogate for Duchenne muscular dystrophy. FEBS Journal 2013 280 17 4177 4186 10.1111/febs.12267 2-s2.0-84882662040
88. Dezawa M., Ishikawa H., Itokazu Y., Yoshihara T., Hoshino M., Takeda S., Ide C., Nabeshima Y., Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005 309 5732 314 317 10.1126/science.1110364 2-s2.0-22044450950 (Pubitemid 40967871)
89. Farini A., Meregalli M., Belicchi M., Battistelli M., Parolini D., D'Antona G., Gavina M., Ottoboni L., Constantin G., Bottinelli R., Torrente Y., T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse. Journal of Pathology 2007 213 2 229 238 10.1002/path.2213 2-s2.0-35349000178 (Pubitemid 47612245)
90. Arpke R. W., Darabi R., Mader T. L., Zhang Y., Toyama A., Lonetree C., Nash N., Lowe D. A., Perlingeiro R. C. R., Kyba M., A new immuno-, dystrophin-deficient model, the NSG-mdx4Cv mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation. Stem Cells 2013 31 8 1611 1620 10.1002/stem.1402 2-s2.0-84877261357
91. Vallese D., Negroni E., Duguez S., Ferry A., Trollet C., Aamiri A., Vosshenrich C. A., Fuchtbauer E. M., Di Santo J. P., Vitiello L., Butler-Browne G., Mouly V., The Rag2(-)Il2rb(-)Dmd(-) mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies, M. Molecular Therapy 2013 21 1950
92. Tedesco F. S., Gerli M. F. M., Perani L., Benedetti S., Ungaro F., Cassano M., Antonini S., Tagliafico E., Artusi V., Longa E., Tonlorenzi R., Ragazzi M., Calderazzi G., Hoshiya H., Cappellari O., Mora M., Schoser B., Schneiderat P., Oshimura M., Bottinelli R., Sampaolesi M., Torrente Y., Broccoli V., Cossu G., Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Science Translational Medicine 2012 4 140 140ra89 10.1126/scitranslmed.3003541 2-s2.0-84863185444
93. Díaz-Manera J., Touvier T., Dellavalle A., Tonlorenzi R., Tedesco F. S., Messina G., Meregalli M., Navarro C., Perani L., Bonfanti C., Illa I., Torrente Y., Cossu G., Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy. Cell Death & Disease 2010 1 8, article e61 10.1038/cddis.2010.35 2-s2.0-79959947941
94. Filareto A., Darabi R., Perlingeiro R. C., Engraftment of ES-derived myogenic progenitors in a severe mouse model of muscular dystrophy. Journal of Stem Cell Research & Therapy 2012 10 1, article S10-001 10.4172/2157-7633. S10-001 2-s2.0-70349741336
95. Kornegay J. N., Tuler S. M., Miller D. M., Levesque D. C., Muscular dystrophy in a litter of golden retriever dogs. Muscle and Nerve 1988 11 10 1056 1064 10.1002/mus.880111008 2-s2.0-0023706738
96. Sharp N. J. H., Kornegay J. N., van Camp S. D., Herbstreith M. H., Secore S. L., Kettle S., Hung W.-., Constantinou C. D., Dykstra M. J., Roses A. D., Bartlett R. J., An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 1992 13 1 115 121 10.1016/0888-7543(92)90210-J 2-s2.0-0026538578
97. Shimatsu Y., Katagiri K., Furuta T., Nakura M., Tanioka Y., Yuasa K., Tomohiro M., Kornegay J. N., Nonaka I., Takeda S., Canine X-linked muscular dystrophy in Japan (CXMDJ). Experimental Animals 2003 52 2 93 97 10.1538/expanim.52.93 2-s2.0-0038117843 (Pubitemid 41349972)
98. Sampaolesi M., Blot S., D'Antona G., Granger N., Tonlorenzi R., Innocenzi A., Mognol P., Thibaud J., Galvez B. G., Barthélémy I., Perani L., Mantero S., Guttinger M., Pansarasa O., Rinaldi C., Cusella De Angelis M. G., Torrente Y., Bordignon C., Bottinelli R., Cossu G., Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006 444 7119 574 579 10.1038/nature05282 2-s2.0-33845257119 (Pubitemid 44864430)
99. Nitahara-Kasahara Y., Hayashita-Kinoh H., Ohshima-Hosoyama S., Okada H., Wada-Maeda M., Nakamura A., Okada T., Takeda S., Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with duchenne muscular dystrophy. Molecular Therapy 2012 20 1 168 177 10.1038/mt.2011.181 2-s2.0-84856963592
100. Rouger K., Larcher T., Dubreil L., Deschamps J., Le Guiner C., Jouvion G., Delorme B., Lieubeau B., Carlus M., Fornasari B., Theret M., Orlando P., Ledevin M., Zuber C., Leroux I., Deleau S., Guigand L., Testault I., Le Rumeur E., Fiszman M., Chérel Y., Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs. The American Journal of Pathology 2011 179 5 2501 2518 10.1016/j.ajpath.2011.07.022 2-s2.0-80055017455
101. Klymiuk N., Blutke A., Graf A., Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle. Human Molecular Genetics 2013 22 4368 4382 10.1093/hmg/ddt287
102. Skuk D., Goulet M., Roy B., Tremblay J. P., Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans. Experimental Neurology 2002 175 1 112 126 10.1006/exnr.2002.7899 2-s2.0-0036255397 (Pubitemid 34507914)
103. Noguchi S., Tsukahara T., Fujita M., Kurokawa R., Tachikawa M., Toda T., Tsujimoto A., Arahata K., Nishino I., cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Human Molecular Genetics 2003 12 6 595 600 10.1093/hmg/12.6.595 2-s2.0-0037444212 (Pubitemid 36372487)
104. Pescatori M., Broccolini A., Minetti C., Bertini E., Bruno C., D'Amico A., Bernardini C., Mirabella M., Silvestri G., Giglio V., Modoni A., Pedemonte M., Tasca G., Galluzzi G., Mercuri E., Tonali P. A., Ricci E., Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB Journal 2007 21 4 1210 1226 10.1096/fj.06-7285com 2-s2.0-33947655852 (Pubitemid 46495710)
105. English K., Wood K. J., Mesenchymal stromal cells in transplantation rejection and tolerance. Cold Spring Harbor Perspectives in Medicine 2013 3 5 a015560 10.1101/cshperspect.a015560 2-s2.0-84878959212
106. Gang E. J., Darabi R., Bosnakovski D., Xu Z., Kamm K. E., Kyba M., Perlingeiro R. C. R., Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery. Experimental Cell Research 2009 315 15 2624 2636 10.1016/j.yexcr.2009.05.009 2-s2.0-67651089683
107. Guttinger M., Tafi E., Battaglia M., Coletta M., Cossu G., Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice. Experimental Cell Research 2006 312 19 3872 3879 10.1016/j.yexcr.2006.08.012 2-s2.0-33750426771 (Pubitemid 44637178)
108. Nauta A. J., Westerhuis G., Kruisselbrink A. B., Lurvink E. G. A., Willemze R., Fibbe W. E., Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006 108 6 2114 2120 10.1182/blood-2005-11-011650 2-s2.0-33746514768 (Pubitemid 44395028)
109. Gregorevic P., Allen J. M., Minami E., Blankinship M. J., Haraguchi M., Meuse L., Finn E., Adams M. E., Froehner S. C., Murry C. E., Chamberlain J. S., rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nature Medicine 2006 12 7 787 789 10.1038/nm1439 2-s2.0-33745894322 (Pubitemid 44050067)
110. Mingozzi F., Meulenberg J. J., Hui D. J., Basner-Tschakarjan E., Hasbrouck N. C., Edmonson S. A., Hutnick N. A., Betts M. R., Kastelein J. J., Stroes E. S., High K. A., AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells. Blood 2009 114 10 2077 2086 10.1182/blood-2008-07-167510 2-s2.0-69949160511
111. Mendell J. R., Campbell K., Rodino-Klapac L., Sahenk Z., Shilling C., Lewis S., Bowles D., Gray S., Li C., Galloway G., Malik V., Coley B., Clark K. R., Li J., Xiao X., Samulski J., McPhee S. W., Samulski R. J., Walker C. M., Dystrophin immunity in Duchenne's muscular dystrophy. The New England Journal of Medicine 2010 363 15 1429 1437 10.1056/NEJMoa1000228 2-s2.0-77957725001
112. Wood K. J., Bushell A., Hester J., Regulatory immune cells in transplantation. Nature Reviews Immunology 2012 12 6 417 430 10.1038/nri3227 2-s2.0-84861568296
113. Mingozzi F., Liu Y., Dobrzynski E., Kaufhold A., Liu J. H., Wang Y., Arruda V. R., High K. A., Herzog R. W., Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. Journal of Clinical Investigation 2003 111 9 1347 1356 10.1172/JCI200316887 2-s2.0-0037988905 (Pubitemid 36554705)
114. Annoni A., Cantore A., Valle D. P., Goudy K., Akbarpour M., Russo F., Bartolaccini S., D'Angelo A., Roncarolo M. G., Naldini L., Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice. EMBO Molecular Medicine 2013 5 11 1684 1697 10.1002/emmm.201302857
115. Burzyn D., Kuswanto W., Kolodin D., Shadrach J. L., Cerletti M., Jang Y., Sefik E., Tan T. G., Wagers A. J., Benoist C., Mathis D., A special population of regulatory T cells potentiates muscle repair. Cell 2013 155 1282 1295 10.1016/j.cell.2013.10.054
116. Kelly C. M., Precious S. V., Scherf C., Penketh R., Amso N. N., Battersby A., Allen N. D., Dunnett S. B., Rosser A. E., Neonatal desensitization allows long-term survival of neural xenotransplants without immunosuppression. Nature Methods 2009 6 4 271 273 10.1038/nmeth.1308 2-s2.0-63949088558
117. Takenaka K., Prasolava T. K., Wang J. C. Y., Mortin-Toth S. M., Khalouei S., Gan O. I., Dick J. E., Danska J. S., Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nature Immunology 2007 8 12 1313 1323 10.1038/ni1527 2-s2.0-36248956243 (Pubitemid 350138972)
118. Jaiswal S., Jamieson C. H. M., Pang W. W., Park C. Y., Chao M. P., Majeti R., Traver D., van Rooijen N., Weissman I. L., CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009 138 2 271 285 10.1016/j.cell.2009.05.046 2-s2.0-67650646082
119. Partridge T. A., Morgan J. E., Coulton G. R., Hoffman E. P., Kunkel L. M., Conversion of mdx myofibres from dystrophin-negative to-positive by injection of normal myoblasts. Nature 1989 337 176 179 10.1038/337176a0 2-s2.0-0024540879 (Pubitemid 19025378)
120. Partridge T., The current status of myoblast transfer. Neurological Sciences 2000 21 9 S939 S942 10.1007/s100720070007 2-s2.0-0034576937 (Pubitemid 33621624)
121. Tremblay J. P., Malouin F., Roy R., Huard J., Bouchard J. P., Satoh A., Richards C. L., Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplantation 1993 2 2 99 112 2-s2.0-0027166930 (Pubitemid 23134486)
122. Guerette B., Asselin I., Vilquin J. T., Roy R., Tremblay J. P., Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle & Nerve 1995 18 1 39 51 10.1002/mus.880180107 2-s2.0-0028814577
123. Kinoshita I., Vilquin J.-T., Guerette B., Asselin I., Roy R., Tremblay J. P., Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle and Nerve 1994 17 12 1407 1415 10.1002/mus.880171210 2-s2.0-0028029771 (Pubitemid 24362813)
124. Skuk D., Caron N., Goulet M., Roy B., Espinosa F., Tremblay J. P., Dynamics of the early immune cellular reactions after myogenic cell transplantation. Cell Transplantation 2002 11 7 671 681 2-s2.0-0036914209 (Pubitemid 36026445)
125. Beauchamp J. R., Morgan J. E., Pagel C. N., Partridge T. A., Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. The Journal of Cell Biology 1999 144 6 1113 1122 10.1083/jcb.144.6.1113 2-s2.0-0033594119 (Pubitemid 29157292)
126. Sammels L. M., Bosio E., Fragall C. T., Grounds M. D., van Rooijen N., Beilharz M. W., Innate inflammatory cells are not responsible for early death of donor myoblasts after myoblast transfer therapy. Transplantation 2004 77 12 1790 1797 10.1097/01.TP.0000131150.76841.75 2-s2.0-3042521537 (Pubitemid 38822198)
127. Skuk D., Paradis M., Goulet M., Tremblay J. P., Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies. Transplantation 2007 84 10 1307 1315 10.1097/01.tp.0000288322.94252.22 2-s2.0-38449092344 (Pubitemid 351339319)
128. Skuk D., Goulet M., Roy B., Chapdelaine P., Bouchard J., Roy R., Dugré F. J., Sylvain M., Lachance J., Deschênes L., Senay H., Tremblay J. P., Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. Journal of Neuropathology and Experimental Neurology 2006 65 4 371 386 10.1097/01.jnen. 0000218443.45782.81 2-s2.0-33744983289 (Pubitemid 44264834)
129. Perie S., Trollet C., Mouly V., Vanneaux V., Mamchaoui K., Bouazza B., Marolleau J. P., Laforet P., Chapon F., Eymard B., Butler-Browne G., Larghero J., St Guily J. L., Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase i/iia clinical study. Molecular Therapy 2014 22 1 219 225 10.1038/mt.2013.155
130. Benveniste O., Guiguet M., Freebody J., Dubourg O., Squier W., Maisonobe T., Stojkovic T., Leite M. I., Allenbach Y., Herson S., Brady S., Eymard B., Hilton-Jones D., Long-term observational study of sporadic inclusion body myositis. Brain 2011 134 11 3176 3184 10.1093/brain/awr213 2-s2.0-81055125519
131. Mendell J. R., Rodino-Klapac L. R., Rosales X. Q., Coley B. D., Galloway G., Lewis S., Malik V., Shilling C., Byrne B. J., Conlon T., Campbell K. J., Bremer W. G., Taylor L. E., Flanigan K. M., Gastier-Foster J. M., Astbury C., Kota J., Sahenk Z., Walker C. M., Clark K. R., Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D. Annals of Neurology 2010 68 5 629 638 10.1002/ana.22251 2-s2.0-78249253608
132. Torrente Y., Belicchi M., Marchesi C., D'Antona G., Cogiamanian F., Pisati F., Gavina M., Giordano R., Tonlorenzi R., Fagiolari G., Lamperti C., Porretti L., Lopa R., Sampaolesi M., Vicentini L., Grimoldi N., Tiberio F., Songa V., Baratta P., Prelle A., Forzenigo L., Guglieri M., Pansarasa O., Rinaldi C., Mouly V., Butler-Browne G. S., Comi G. P., Biondetti P., Moggio M., Gaini S. M., Stocchetti N., Priori A., D'Angelo M. G., Turconi A., Bottinelli R., Cossu G., Rebulla P., Bresolin N., Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplantation 2007 16 6 563 577 2-s2.0-36248950999 (Pubitemid 351448271)
133. Lerario A., Bonfiglio S., Sormani M., Tettamanti A., Marktel S., Napolitano S., Previtali S., Scarlato M., Natali-Sora M., Mercuri E., Bresolin N., Mongini T., Comi G., Gatti R., Ciceri F., Cossu G., Torrente Y., Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures. BMC Neurology 2012 12, article 91 10.1186/1471-2377-12-91 2-s2.0-84866064194
134. Giannotta M., Benedetti S., Tedesco F. S., Corada M., Trani M., D'Antuono R., Millet Q., Orsenigo F., Galvez B. G., Cossu G., Dejana E., Targeting endothelial junctional adhesion molecule-A/EPAC/Rap-1 axis as a novel strategy to increase stem cell engraftment in dystrophic muscles. EMBO Molecular Medicine 2014 66 2 239 258
135. Tedesco F. S., Hoshiya H., D'Antona G., Gerli M. F., Messina G., Antonini S., Tonlorenzi R., Benedetti S., Berghella L., Torrente Y., Kazuki Y., Bottinelli R., Oshimura M., Cossu G., Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy. Science Translational Medicine 2011 3, article 96ra78
136. Gerli M. F., Maffioletti S. M., Millet Q., Tedesco F. S., Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration. Journal of Visualized Experiments 2014 83 e50532